Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

SmithKline Beecham and Fournier enter agreement for new antithrombotic

July 7, 1999

New cardiovascular disease candidate from Merck KGaA enters phase II

July 6, 1999

Novel glycoside antithrombotic agents in the pipeline at Gedeon Richter

July 6, 1999

Pharming begins phase I development of human lactoferrin

July 5, 1999

DuPont files NDA for Innohep for treatment and prevention of deep vein thrombosis

July 2, 1999

Corvas presents novel peptide aldehydes as thrombin inhibitors

July 1, 1999

Roberts buys rights to Agrylin from Bristol-Myers Squibb

June 29, 1999

One-year NINDS study results on t-PA for acute ischemic stroke

June 29, 1999

Thrombin-inhibitory anticoagulants prepared by Merck scientists

June 28, 1999

Another series of factor Xa inhibitors patented by AxyS

June 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...